Neovascular Age-related Macular Degeneration: Intraocular Cytokines and Growth Factors and the Influence of Therapy with Ranibizumab

Ophthalmology

Volumn 116, Issue 12, 2009, Pages 2393-2399

  Funk, Marion ^a   Karl, David ^a   Georgopoulos, Michael ^a   Benesch, Thomas ^a   Sacu, Stefan ^a   Polak, Kaija ^a   Zlabinger, Gerhard J ^b   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; EOTAXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; RANIBIZUMAB; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AGED; AQUEOUS HUMOR; ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; THICKNESS; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; AQUEOUS HUMOR; CHOROIDAL NEOVASCULARIZATION; CYTOKINES; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACULAR DEGENERATION; PROSPECTIVE STUDIES; VISUAL ACUITY; VITREOUS BODY;

EID: 70649094281     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.05.039     Document Type: Article

References (30)

1. Aiello L.P., Avery R.L., Arrigg P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 (1994) 1480-1487
2. Tong J.P., Chan W.M., Liu D.T., et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 141 (2006) 456-462
3. Noma H., Funatsu H., Yamasaki M., et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22 (2008) 42-48
4. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25 (2004) 581-611
5. Yi X., Mai L.C., Uyama M., and Yew D.T. Time-course expression of vascular endothelial growth factor as related to the development of the retinochoroidal vasculature in rats. Exp Brain Res 118 (1998) 155-160
6. Stone J., Itin A., Alon T., et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15 (1995) 4738-4747
7. Aiello L.P., Northrup J.M., Keyt B.A., et al. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113 (1995) 1538-1544
8. Gaudry M., Bregerie O., Andrieu V., et al. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 90 (1997) 4153-4161
9. Wartiovaara U., Salven P., Mikkola H., et al. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 80 (1998) 171-175
10. Ishida S., Usui T., Yamashiro K., et al. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med 198 (2003) 483-489
11. Ferrara N., and Kerbel R.S. Angiogenesis as a therapeutic target. Nature 438 (2005) 967-974
12. Rosenfeld P.J., Brown D.M., Heier J.S., et al., MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
13. Chun D.W., Heier J.S., Topping T.M., et al. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology 113 (2006) 1706-1712
14. Kvanta A., Algvere P.V., Berglin L., and Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37 (1996) 1929-1934
15. Grossniklaus H.E., Ling J.X., Wallace T.M., et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 8 (2002) 119-126
16. Blaauwgeers H.G., Holtkamp G.M., Rutten H., et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris: evidence for a trophic paracrine relation. Am J Pathol 155 (1999) 421-428
17. Yoshida M., Tanihara H., and Yoshimura N. Platelet-derived growth factor gene expression in cultured human retinal pigment epithelial cells. Biochem Biophys Res Commun 189 (1992) 66-71
18. Heldin C.H., Ostman A., and Rönnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1378 (1998) F79-F113
19. Lindahl P., Johansson B.R., Levéen P., and Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277 (1997) 242-245
20. Kliffen M., Sharma H.S., Mooy C.M., et al. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 81 (1997) 154-162
21. Browning A.C., Dua H.S., and Amoaku W.M. The effects of growth factors on the proliferation and in vitro angiogenesis of human macular inner choroidal endothelial cells. Br J Ophthalmol 92 (2008) 1003-1008
22. Wilkinson-Berka J.L., Babic S., De Gooyer T., et al. Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. Am J Pathol 164 (2004) 1263-1273
23. Yamada H., Yamada E., Ando A., et al. Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy. Am J Pathol 156 (2000) 477-487
24. Yamada K., Sakurai E., Itaya M., et al. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. Invest Ophthalmol Vis Sci 48 (2007) 1839-1843
25. Shi X., Semkova I., Muther P.S., et al. Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization. Exp Eye Res 83 (2006) 1325-1334
26. Apte R.S., Richter J., Herndon J., and Ferguson T.A. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 3 (2006) e310
27. Ooi K.G., Galatowicz G., Towler H.M., et al. Multiplex cytokine detection versus ELISA for aqueous humor: IL-5, IL-10, and IFNgamma profiles in uveitis. Invest Ophthalmol Vis Sci 47 (2006) 272-277
28. Takase H., Futagami Y., Yoshida T., et al. Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci 47 (2006) 1557-1561
29. Gaudreault J., Fei D., Rusit J., et al. Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci 46 (2005) 726-733
30. Gaudreault J., Fei D., Beyer J.C., et al. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits. Retina 27 (2007) 1260-1266